Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Canntab Therapeutics Ltd C.PILL

Alternate Symbol(s):  CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and... see more

Recent & Breaking News (CSE:PILL)

InvestmentPitch Media Video Discusses Canntab Approaching Revenue under FSD Pharma's New "Sale for Medical Purposes" Cannabis License - Video Available on Investmentpitch.com

Newsfile April 24, 2019

Canntab Advances its Revenue Model with Recent Sales License Approval for FSD Pharma from Health Canada

Canada NewsWire April 23, 2019

Canntab Therapeutics Announces Engagement of Relations Publiques Paradox Inc. for Investor Relations Services

GlobeNewswire March 28, 2019

Canntab Enters into Five Year Supply and Loan Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal

GlobeNewswire February 28, 2019

Canntab Provides Corporate Update

GlobeNewswire February 19, 2019

Canntab Enters into Supply Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal

GlobeNewswire February 12, 2019

FSD Pharma & Canntab Rank Among the Top 2018 Cannabis Stocks -- CFN Media

GlobeNewswire January 17, 2019

Canntab & FSD Pharma Make Cannabis More Palatable for Doctors -- CFN Media

GlobeNewswire December 21, 2018

Canntab Partners with Leading Surgeon to Conduct Pain Management Trial -- CFN Media

GlobeNewswire December 13, 2018

Canntab Enters Into a Binding Term Sheet With Leading Orthopaedic Surgeon Dr. Don Garbuz, M.D. for a Clinical Research Trial of Canntab’s Tablets

GlobeNewswire December 5, 2018

Canntab Nears Commercialization with Innovative Cannabis Tablets-- CFN Media

GlobeNewswire November 29, 2018

Canntab Announces Correction to Press Release 

GlobeNewswire November 14, 2018

Canntab Corporate Update

GlobeNewswire November 14, 2018

Canntab to Enter Medicinal Cannabis Market in Mexico

GlobeNewswire October 31, 2018

InvestmentPitch Media Video Discusses Canntab Therapeutics and its Application to Become a Licensed Producer Under ACMPR with Health Canada - Video News Alert on Investmentpitch.com

Newsfile October 22, 2018

Canntab Files Application to Become Licensed Producer

GlobeNewswire October 19, 2018

Canntab Files Application to Become Licensed Producer

Newsfile October 18, 2018

Canntab Therapeutics, Extended Release Cannabis Tablets, CEO Clip Video

Newsfile October 4, 2018

InvestmentPitch Media Video Discusses Canntab Therapeutics LOI With NewCanna of Colombia to Distribute Canntab Products in Select Countries - Video News Alert on Investmentpitch.com

Newsfile October 4, 2018

Canntab Enters LOI for Bi-Lateral Sales & Distribution and Cannabis Oil Supply

Newsfile October 1, 2018